. DCUN1D5 cDNA encoded a protein of 237 amino acids, which contained two domains associated with DNA repair and cell cycle regulation (Kurz et al., 2005; Yang et al., 2007) . Although no reported studies have clearly demonstrated DCUN1D5's role in cancer, one report suggested that DCUN1D5 expression may be useful as a biomarker for cervical cancer (Rajkumar et al., 2009) .
Because DNA damage and repair pathways played critical roles in the development of LSCC, a smokingrelated cancer, and because DCUN1D5 was found to be up-regulated in our patients with LSCC who had a tobacco history, we hypothesized that DCUN1D5 had a vital function involved in DNA damage response and repair in the carcinogenesis of LSCC.
Materials and Methods

Cell lines and tumor tissue
HeLa (cervical adenocarcinoma) cells and Hep2 (LSCC) cells obtained from the American Type Culture Collection (ATCC) were cultured in RPMI 1640 medium with 10% fetal bovine serum (FBS). Primary laryngeal tumors and adjacent paired noncancerous normal tissues were collected from patients undergoing surgical resection at Beijing Tongren Hospital, after the patients provided informed consent and the local ethics committee approved the study. Tissue samples were snap frozen in aliquots and stored in liquid nitrogen for gene microarray analysis.
Microarray analysis
A human genome oligonucleotide set (version 2.0) consisting of 5' amino acid-modified 70-mer probes and representing 21,329 well-characterized Homo sapiens genes was purchased from Operon. RNA from primary tumors and paired noncancerous normal tissues was isolated and reverse-transcribed to the cDNA. Quantification and normalization of intensity signals were performed using LuxScan 3.0 software (CapitalBio, China) . Normalized log ratios of gene expression for all samples were imported into SAM software. Genes whose expression patterns were altered in LSCC were input into the EASE software under the ''GO biological process'' category of the Gene Ontology Consortium (Tusher et al., 2001; Cavalieri et al., 2007) .
Reverse transcriptase polymerase chain reaction (RT-PCR)
The primers used for RT-PCR of DCUN1D5 were 5'-GCTAGACTAATAAGTGGAGAGGA-3' and 5'-CAGTCACACTGTAATGAAGTCAT-3'. The PCR designed to amplify the 242-bp fragment (386-628 bp) was performed at 94 ℃ for 5 min, 30 cycles of 94 for 30 s, 58 ℃ for 30 s, and 72 ℃ for 30 s followed by extension at 72 ℃ for 7 min. The relative fold increase of DCUN1D5 expression was determined by using glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as a control.
Immunohistochemical analysis
Paraffin-embedded tissue samples were prepared for immunohistochemical analysis by anti-DCUN1D5 antibody (1:1000, Protein Tech Inc., China) using the immunohistochemical method, as described previously (Zhong et al., 2011) .
Molecular cloning and subcellular localization
DCUN1D5-ORF was cloned into a pOTB7 vector (Protein Tech Inc., China), sequenced using the ABI Prism 3100 genetic analyzer (Applied Biosystems, USA) and subcloned into the EcoRI and XhoI sites of the mammalian expression vector, pcDNA.3.1/myc-His(-) B (pCDB) (Invitrogen), and the pEGFP-N1 expression vector (Clontech).
Hep2 cells were cotransfected with DCUN1D5-pEGFP-N1 and an endoplasmic reticulum-specific plasmid (donated by Peking University, China). After a 24-h incubation, cells were stained with 4', 6-diamidino-2-phenylindole (DAPI) and imaged by immunofluorescence microscopy (IX71-141, Olympus, Japan).
Ultraviolet C (UVC) exposure
HeLa cells grown to 60% to 80% confluence in 6-well plates were washed twice in phosphate-buffered saline (PBS) and then overlaid with 2 ml of PBS at 37 °C. The lids were removed and the cells were exposed to UVC light (254 nm) at a dose of 40 J/m 2 for 10 min, 40 J/m 2 for 15 min, 80 J/m 2 for 10 min, and 80 J/m 2 for 15 min. The medium was then replaced, and the cells were harvested at 0, 24, or 48 h for in vitro analysis.
Western blot analysis
Whole cell protein extracts were prepared in RIPA lysis buffer. Equal amounts of cell lysates were added with 5 x Tris-glycine sodium dodecyl sulfate (SDS) sample buffer, subjected to electrophoresis on an SDS/15% polyacrylamide gel, and transferred to a nitrocellulose membrane (Amersham Pharmacia, UK). Proteins were detected with use of monoclonal rabbit anti-DCUN1D5 antibody (1:1000, Protein Tech Inc., China). The blots were scanned with use of the Odyssey Imaging System (LI-COR Bioscience, USA). The expression of β-actin protein was used as a control.
Wound healing assay
Hep2 cells were seeded in 6-well plates at a density of 100,000 cells per well and grown to a monolayer. A scratch in the monolayer was made using a 10-µl pipette tip. The debris was washed away with PBS, and cells were incubated in serum-free medium. Cells of same regions along the wound area were imaged at 0, 24, and 48 h. Inverted fluorescence microscopy (IX71-141, Olympus, Japan) was used to identify the average width of the area devoid of cells.
Matrigel invasion assay
Hep2 cell invasion was quantified with use of a BD Matrigel Invasion Chamber fitted with an 8.0-µm PET membrane (BD Biosciences). The membrane was soaked in RPMI 1640 medium and incubated at 37 °C for 2 h. The bottom well contained high-glucose RPMI 1640 medium containing 5% FBS. Cells were added to the upper well and incubated in serum-free medium. After 24 h of incubation, the cells on the upper surface were removed by wiping with a cotton swab. The membrane was stained with hematoxylin and eosin, and cell invasion was determined by counting 10 randomly selected fields.
Colony formation assay
Hep2 cells were plated in 6-cm dishes at 2 x 10 4 cells/ cm 2 and transfected with DCUN1D5, pCDB, and H-RAS separately. Cells were then harvested by trypsinization after incubation of 24 h and replated in 6-well plates at a density of 5 x 10 2 cells/ml. After 2 weeks of G418 selection (500 μg/ml), colonies were fixed, stained with crystal violet, and counted.
Cell cycle and apoptosis analysis
HeLa cells were grown in 6-well plates to 60% confluence and transiently transfected with siRNAs at a final concentration of 100 nM. Cells were collected at 24 h after post-transfection and washed twice with PBS. For cell apoptosis measurement, cells were resuspended in 1× binding buffer, and 5 µl of annexin fluorescein isothiocyanate (FITC) conjugate and 10 µl of propidium iodide (50 μg/ml) solution were added to each cell suspension, separately. For cell cycle analysis, the cells were fixed in 70% ethanol overnight at 4oC and were resuspended in staining solution (50 μg/ml of propidium iodide, 1 mg/ml of RNase A, and 0.1% Triton X-100 
Statistical analysis
Data were reported as mean ± SD or as median (range). Each experiment was repeated at least three times. Statistical significance of the differences between experimental groups was determined by Student's t test. The χ 2 test was used to evaluate the differences in the distributions of selected demographic characteristics between DCUN1D5 positive and DCUN1D5 negative cases. All analyses were two sided. Values of p < 0.05 were considered statistically significant.
Results
Genomic gene expression sequence analysis and prediction
Differential patterns in gene expression between five paired LSCC samples and paired normal tissues were determined based on the average log ratios. Among the 20 highest-ranked genes from microarray data (Table 1) , DCUN1D5 was the only gene whose function was not yet known.
DCUN1D5 protein (NP_115675) contained two domains, including a DCN1 domain, which was a scaffoldlike E3 ligase for cullin neddylation that displayed ubiquitin ligase activity, and a DUF298 domain of unknown function. Members of the DUF family contained a basic helix-loop-helix leucine zipper motif, which was implicated in some aspects of neddylation of the cullin 3 family and had a possible role, along with the DCN1 domain, in the regulation of DNA repair and cell cycle progression (Kurz et al., 2005; Yang et al., 2007) .
DCUN1D5 expression in human cancer cell lines
RT-PCR was performed to identify the transcriptional level of DCUN1D5 in 10 human cancer cell lines (Fig.  1a) . Semi-quantitative results revealed that the relative expression levels of DCUN1D5 differed across various cell lines. Normalization of the data to GAPDH indicated that DCUN1D5 was moderately to highly expressed in Hep2 and HeLa cells (Figure 1b) .
DCUN1D5 overexpression in primary LSCC tissues
The correlations between DCUN1D5 expression and age, sex, smoking, alcohol use, histology, and cancer staging among 50 LSCC patients were shown in Table  2 . DCUN1D5 protein was overexpressed in 12 (24.0%) of 50 squamous epithelial cancerous tissue samples from 50 LSCC patients and negative expressed in all paired noncancerous normal tissues. 40 primary LSCCs and 10 precancerous lesions were analyzed in all, resulting in the detection of positive nuclear DCUN1D5 immunoreactivity in 11 (27.5%) LSCCs and 1 (10.0%) precancerous lesion, respectively (Table 2) . Moreover, all of the patients with positive LSCCs had a smoking history. No differences in DCUN1D5 immunoreactivity were observed between different tumor-node-metastasis (TNM) stages (p = 0.50) or histologic subgroups (p = 0.42). We found that endogenous DCUN1D5 localized to the nucleus in squamous epithelial cancerous tissues (Figure 1c1-4) . Pathology was confirmed in all samples by hematoxylin and eosin staining (Figure 1c-5) . Interestingly, we observed DCUN1D5-positive plasma cells surrounding the epithelial cells in 5 LSCC patients (Figure 1c-2) .
Subcellular localization of DCUN1D5
Similar to the results of immunohistochemistry in squamous epithelial cancerous tissues (Figure 1c) , subcellular localization analysis indicated that endogenous DCUN1D5 localized to the nucleus in Hep2 cells ( Figure  1d ) and HeLa cells.
UVC exposure reduced endogenous DCUN1D5 expression
RT-PCR analysis showed that endogenous expression of DCUN1D5 decreased in a time-dependent manner after UVC treatment (Figure 2a, b) . Western blot analysis was performed to determine DCUN1D5 protein levels at 0, 12 and 24 h intervals. Endogenous DCUN1D5 protein expression was also decreased in a time-dependent manner after UVC exposure (Figure 2c, d) .
Overexpression of DCUN1D5 increased cell migration, invasion, and proliferation in vitro, but not apoptosis
A wound healing assay was performed to detect the migration ability of Hep2 cells. Phase-contrast microscopy imaging revealed that overexpression of DCUN1D5 resulted in 2.7 times greater migration to the wound area at 24 h compared with the pCDB-treated controls ( Figure  3a, b) .
A Matrigel invasion assay was used to investigate the role of DCUN1D5 in cell invasion. Overexpression of DCUN1D5 protein resulted in increased Hep2 cells invasion, as the number of cells proceeded through the membrane increased by 67.5% compared with the pCDBtreated (Figure 3c, d) .
Further, a colony formation assay was performed to DOI:http://dx.doi.org/10.7314/APJCP.2012.13.8.4157 In Vitro Biological Characterization of DCUN1D5 in DNA Damage Response determine the impact of DCUN1D5 expression on Hep2 cells proliferation. Significantly larger colonies were observed following overexpression of DCUN1D5, and 2.6 times more colonies were quantified compared with the pCDB-treated controls (Figure 3e, f) .
To determine the impact of DCUN1D5 expression on apoptosis, Hep2 cells were harvested 24 h after transfection, and apoptosis was analyzed by the FACS method. Data indicated that the percentage of apoptotic cells did not differ significantly between cells overexpressing DCUN1D5 and controls (Figure 3g, h) .
Knockdown of DCUN1D5 blocked S phase progression and increased apoptosis after UVC irradiation in vitro
The DCUN1D5-siRNA-3 was identified and chosen for subsequent knockdown studies, because DCUN1D5 mRNA was significantly decreased 24 h after transfection in HeLa cells (Figure 4a ). Cell cycle results indicated that DCUN1D5-siRNA-3 decreased the number of cells in the S phase by 10.2% compared with controls after UVC treatment, whereas the number of cells in the S phase increased by 4.5% without UVC exposure (Figure 4b, c) . Similarly, DCUN1D5-siRNA-3-treated cells displayed an 11.7% increase in apoptosis compared with controls after UVC treatment, whereas the number of apoptosis cells increased by 0.9% without UVC exposure (Figure 4d , e).
Discussion
Smoking is a primary risk factor for laryngeal carcinogenesis because chemicals in cigarette can modify and mutate DNA (Khlifi et al., 2010; Mallis et al., 2011) . Neoplasms induced by tobacco smoking have more complex etiology because of the presence of various carcinogenic agents (Slebos et al., 2002; Hang B, 2010) . High-density microarray expression profiling can be a valuable tool for identifying putative genes involved in critical cellular activities (Chung et al., 2004; Chen et al., 2010) .
We utilized microarray analysis to identify DCUN1D5, a UVC-responsive gene that affected cell cycle progression and apoptosis following genotoxic shock. Overexpression of DCUN1D5 promoted the proliferation, migration, and invasion in vitro, with no impact on apoptosis. After exposure to UVC irradiation, endogenous DCUN1D5 expression decreased in a time-dependent manner. Moreover, siRNA silencing of DCUN1D5 decreased the number of cells in the S phase and increased apoptosis after UVC exposure. To our knowledge, these data are the first to identify a role of DCUN1D5 contributing to SCC progression. Further, these data suggest that DCUN1D5 may have a vital function involved in DNA damage response and provide new clues to yet-unknown signal transduction pathways activated by genotoxic stress.
Useful hints about the function of DCUN1D5 can also be found with the help of bioinformatic tools. Motif analysis (Chen et al., 2009; Eisenhaber et al., 2010) in the MnM database (Minimotif Miner 2.4) indicated that there were three putative binding sites for DNA damage response proteins such as ATM (ataxia-telangiectasia mutated) and ATR (ataxia-telangiectasia and Rad3-related). Additionally, there was a putative Rad53 binding site. Recently, researchers uncovered a novel MEC1-RAD53-DCN1-dependent signaling pathway that prevented deleterious DSB-specific telomerase additions at DNA breaks, thus preserving genomic integrity (Makovets et al., 2009; Kurz et al., 2008) . Taken together, these findings suggested that the DCUN1D5 might play a role in DNA damage response to genotoxic stress and probably subsequent DNA repair. These data were consistent with what we found in cell lines, specifically, that DCUN1D5 had distinct phenotypes and exhibited responsiveness to DNA damage.
UVC irradiation (<280 nm) caused direct DNA photodamage by inducing cyclobutane pyrimidine dimmers that were associated with mutagenesis and tumorigenesis (Pfeifer et al., 2005) . DNA damage following UVC exposure induced G1/S cell cycle arrest (Gentile et al., 2003) . Therefore, the UVC model was chosen to investigate the role of DCUN1D5 in DNA damage response. In our study, we found that siRNA knockdown of endogenous DCUN1D5 expression decreased the percentage of cells in the S phase and increased the percentage of cells undergoing apoptosis after UVC treatment. In contrast, we did not detect any effect of DCUN1D5 on apoptosis in cells that were not exposed to UVC, which suggested that DCUN1D5 might block cell cycle progression to facilitate the repair of damaged DNA. We speculated that DCUN1D5 could have similar roles in DNA repair following cigarette smoke-induced genotoxic stress. However, the precise mechanisms involved in the function of DCUN1D5 in the cell cycle, cell survival, and cell growth require further investigation. Another interesting result of immunohistological analysis revealed that DCUN1D5 was expressed in plasma cells surrounding the epithelial cells. This finding suggested that DCUN1D5 might be involved in host immune response in LSCC. Because the immune system mounted a defense against cancer development and the persistent inflammatory reactions facilitated tumor progression (Bhutia et al., 2010; Gomes et al., 2010) , there was no clear understanding of the immune response in the development of LSCC. Hahne et al reported that melanoma cells bore Apo-1 or Fas on their surfaces, which induced immune cells to initiate apoptosis (Hahne et al., 1996) . The hypothesis that DCUN1D5 may play a role in host immune responses inducing apoptosis needs further study.
Our data describe, for the first time, a role of DCUN1D5 in DNA damage response in vitro. Further studies are needed to elucidate the mechanisms behind the roles of DCUN1D5 involved in DNA damage and repair, for correlations of such findings with additional clinical parameters and prognosis are warranted.
